Organ-specific autoimmune response is the key pathogenic event during the development of autoimmune diseases. Various factors including viral infections, genetic susceptibilities and dysregulated immune responses contribute to organ-specific immunity and promote tissue damage. It has been shown that many immune subsets including T and B cells infiltrate into target organs of patients with organ-specific autoimmune diseases, highlighting the important roles of tissue-specific autoimmune responses in disease pathogenesis (1,2). Recent studies have revealed the extensive crosstalk between tissue cells and infiltrating immune cells, which drive organ-specific inflammation (3). Currently, effective therapies are still lacking for patients with autoimmune diseases, which is largely due to the limited understanding of tissue-specific autoimmune responses. Recent studies have shown that targeting disturbed cytokine network in organs might be an effective therapeutic strategy (4)(5)(6). Therefore, the studies of organ-specific immunity are important for understanding autoimmune disease pathogenesis and will facilitate the development of novel therapies. The current Research Topic focuses on deciphering the organ-specific responses in various autoimmune diseases and provides new insights into the cellular and molecular mechanisms and the clinical implications. As editors of the Research Topic, we present the major contributions of the accepted articles and discuss future perspectives in this important research field. Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease characterized by dysfunction and inflammation of exocrine glands, including salivary glands and lacrimal glands. PSS patients usually show systemic complications with the involvement of multiple extraglandular organs, such as lungs, kidney, and joints (7). Various B and T cell subsets are detected in the inflamed organs of pSS patients. Histopathological and serological examinations are vital for the diagnosis and treatment of organspecific autoimmune diseases. Hakroush et al. validated a recently described scoring system for shortterm treatment response to therapeutic plasma exchange (PLEX) in a cohort of 53 patients with antineutrophil cytoplasmic antibody-associated vasculitis, a small vessel vasculitis affecting multiple organs. The enrolled patients also presented with rapidly progressive glomerulonephritis that was confirmed with histological analysis of kidney biopsies. This study suggests that PLEX scoring together with renal biopsy analysis may represent important prognostic value for predicting poor outcomes in the patient population, which warrants further investigation and validation in large cohorts.In organ-specific autoimmune diabetes mellitus (DM), the combined presence of autoantibodies against glutamic acid decarboxylase (GADA) and the islet-specific cation efflux transporter ZnT8
3 Authors
- GS
Giuseppe Salfi
Istituto di Ricerche Farmacologiche Mario Negri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Italy
- FC
Federica Casiraghi
Istituto di Ricerche Farmacologiche Mario Negri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Italy
- GR
Giuseppe Remuzzi
Istituto di Ricerche Farmacologiche Mario Negri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Italy
8 Authors
- AT
Aldana Trabucchi
Universidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología, Argentina
- SS
Silvina Sonia Bombicino
Universidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología, Argentina
- AV
Adriana Victoria Sabljic
Universidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología, Argentina
- JI
Juan Ignacio Marfía
Universidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología, Argentina
- AM
Alexandra Marisa Targovnik
Universidad de Buenos (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología, Argentina
- RF
Rubén Francisco Iacono
Universidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología, Argentina
- MV
María Victoria Miranda
Universidad de Buenos (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología, Argentina
- SN
Silvina Noemí Valdez
Universidad de Buenos Aires (UBA), Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología, Argentina
3,386 views
7 citations
